LRIG inhibitors of growth factor signalling – double-edged swords in human cancer?

This publication has 43 references indexed in Scilit:

• A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity
  Oncogene, 2006
• LRIG-1 Provides a Novel Prognostic Predictor in Squamous Cell Carcinoma of the Skin: Immunohistochemical Analysis for 38 Cases
  Dermatologic Surgery, 2006
• The Leucine-rich Repeat Protein LRIG1 Is a Negative Regulator of ErbB Family Receptor Tyrosine Kinases
  Journal of Biological Chemistry, 2004
• LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation
  The EMBO Journal, 2004
• The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea
  Genomics, 2004
• Characterization and tissue-specific expression of human LRIG2
  Gene, 2004
• LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
  British Journal of Cancer, 2003
• Is LRIG1 a Tumour Suppressor Gene at Chromosome 3p14.3?
  Acta Oncologica, 2002
• Cloning, Characterization, and Expression of Human LIG1
  Biochemical and Biophysical Research Communications, 2001
• cDNA Cloning of a Novel Membrane Glycoprotein That Is Expressed Specifically in Glial Cells in the Mouse Brain
  Journal of Biological Chemistry, 1996